Mount Vernon Associates’s Merck MRK Stock Holding History

Mount Vernon Associates’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,270	Closed	-$242K	–	51
2023 Q1	$242K	Hold	2,270	–	–	0.29%	47
2022 Q4	$252K	Sell	2,270 -100	-4%	-$10.2K	0.32%	45
2022 Q3	$204K	Hold	2,370	–	–	0.27%	46
2022 Q2	$216K	Sell	2,370 -500	-17%	-$44.3K	0.26%	48
2022 Q1	$235K	Hold	2,870	–	–	0.23%	48
2021 Q4	$220K	Hold	2,870	–	–	0.19%	51
2021 Q3	$216K	Hold	2,870	–	–	0.2%	52
2021 Q2	$223K	Sell	2,870 -138	-5%	-$10.3K	0.2%	51
2021 Q1	$221K	Hold	3,008	–	–	0.22%	51
2020 Q4	$235K	Sell	3,008 -524	-15%	-$40.1K	0.25%	47
2020 Q3	$280K	Hold	3,532	–	–	0.34%	42
2020 Q2	$261K	Hold	3,532	–	–	0.34%	41
2020 Q1	$259K	Sell	3,532 -105	-3%	-$8.25K	0.43%	38
2019 Q4	$316K	Hold	3,637	–	–	0.43%	39
2019 Q3	$292K	Hold	3,637	–	–	0.44%	39
2019 Q2	$291K	Hold	3,637	–	–	0.43%	39
2019 Q1	$289K	Hold	3,637	–	–	0.44%	40
2018 Q4	$265K	Hold	3,637	–	–	0.47%	40
2018 Q3	$246K	Hold	3,637	–	–	0.36%	45
2018 Q2	$211K	Buy	+3,637	New	+$205K	0.33%	49
2017 Q4	–	Sell	-3,637	Closed	-$222K	–	56
2017 Q3	$222K	Hold	3,637	–	–	0.37%	47
2017 Q2	$222K	Sell	3,637 -104	-3%	-$6.33K	0.4%	49
2017 Q1	$227K	Hold	3,741	–	–	0.42%	48
2016 Q4	$210K	Hold	3,741	–	–	0.41%	49
2016 Q3	$223K	Hold	3,741	–	–	0.46%	47
2016 Q2	$206K	Buy	+3,741	New	+$199K	0.44%	51
2015 Q3	–	Sell	-3,878	Closed	-$211K	–	53
2015 Q2	$211K	Hold	3,878	–	–	0.46%	49
2015 Q1	$213K	Buy	+3,878	New	+$220K	0.46%	52

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Mount Vernon Associates's MRK Position: Q2 2023 in Review

Mount Vernon Associates sold out of Merck (MRK) in Q2 2023, closing a stake of 2,270 shares — an estimated $242K sold.

Mount Vernon Associates first reported a position in MRK in Q1 2015 and held it in 28 quarters. The position peaked at $316K in Q4 2019. 3,255 funds tracked by Wall St. Rank hold MRK as of Q2 2023.

Mount Vernon Associates reported no remaining Merck position as of Q2 2023 after selling out during the quarter.
Mount Vernon Associates sold 2,270 Merck shares in Q2 2023, an estimated $242K.
Mount Vernon Associates first reported a position in Merck in Q1 2015 and held it in 28 quarters.
Mount Vernon Associates's Merck position peaked at $316K in Q4 2019.
3,255 funds tracked by Wall St. Rank held Merck as of Q2 2023.

Based on Mount Vernon Associates's 13F filing for Q2 2023, filed 24 Jul 2023.